This randomized, controlled study compared edrophonium dose requirements to antagonize cisatracurium-induced neuromuscular block in children and adults. Sixty children, aged two to 10 years, and 60 adults aged 20 to 60 years, all subjects ASA physical status 1 or 2, having propofol, fentanyl and isoflurane-N 2 O anaesthesia, were studied. Cisatracurium 0.1 mg.kg -1 was given for muscle relaxation. Neuromuscular block was monitored with accelerometry. Edrophonium 0.1, 0.2, 0.4 or 1 mg.kg -1 or no anticholinesterase (controls) was given by random allocation to antagonize 90% neuromuscular block in each of the study groups (n=12). Atropine 5 to 10 µg.kg -1 was given according to edrophonium dose. Onset time of cisatracurium-induced block in children was mean (SD) 2.4 (0.8) versus 4.1 (2.3) minutes in adults, P<0.01. The times to 10% spontaneous recovery of the first twitch (T1) were respectively, 28.4 (5.2) and 41.8 (6.1) minutes in children and adults, P<0.01. Spontaneous and antagonist assisted neuromuscular recovery was more rapid in children. Adequate neuromuscular recovery (train of four (TOF) ratio 80%) was achieved in children at 3 and 10 minutes after edrophonium 1.0 mg.kg -1 and 0.4 mg.kg -1 , respectively. A TOF ratio of 80% was not achieved, within 10 minutes, with any of the four dose levels of edrophonium in adults. The dose of edrophonium to achieve a TOF ratio of 80% (ED TOF-80 ) after 5 and 10 minutes in children were, respectively, mean (SD) 0.85 (0.38) and 0.38 (0.19) mg.kg -1 . The equivalent ED in adults was outside the edrophonium dose range studied.
In the past, larger doses of anticholinesterases were recommended for antagonism of d-tubocurarineinduced neuromuscular blockade in children compared to adults 1 . Later antagonist dose-response studies demonstrated that the dose-response curve for neostigmine antagonism of d-tubocurarineinduced neuromuscular block in children was shifted to the left compared to adults 2 . This finding was subsequently confirmed in antagonist dose-response studies using long 3 , intermediate 4 , and short duration 5 neuromuscular blocking drugs in the two age groups.
A recent review of the use of neuromuscular blockers in paediatric anaesthesia suggested that edrophonium is a better choice than neostigmine for antagonism of residual neuromuscular block 6 . This is mainly due to the fact that edrophonium has a more rapid onset and a shorter time to peak effect compared to neostigmine. The same review recommended the routine use of a high dose of edrophonium (1 mg.kg -1 ) for reliable antagonism of nondepolarizing neuromuscular block in paediatrics. This recent recommendation casts some doubt, at least for edrophonium, on the contention that children require a reduced dose of anticholinesterase compared to adults.
Cisatracurium is a neuromuscular blocking drug of intermediate duration of action and is readily reversible with neostigmine and edrophonium in adults 7 and in children 8 . A recent dose-response study in adults during outpatient anaesthesia demonstrated that, compared to vecuronium, cisatracurium required significantly higher doses of neostigmine to achieve adequate train-of-four (TOF) recovery 9 . To date, dose-response evaluation of the antagonism of cisatracurium with edrophonium has not been carried out in adults or in children. The present study was designed to determine and compare the dose-response relationships for edrophonium antagonism of a 90% residual neuromuscular block (T1=10% of control) after the administration of a single bolus dose of cisatracurium 0.1 mg.kg -1 in children and adults receiving isoflurane/nitrous oxide anaesthesia.
PATIENTS AND METHODS
Sixty children and 60 adult patients, ASA physical status 1 or 2 were studied. Age and weight ranges were: children: 2 to 10 years, 10 to 30 kg; adults: 20 to 60 years, 45 to 80 kg. Patients were undergoing elective ear nose and throat surgery of at least 45 minutes duration, e.g., adenotonsillectomy in children and septoplasty in adults. The Anaesthesiology Department and Cairo University Review Board approved the study. All children's guardians and adult patients gave written informed consent. We excluded from the study any patient with cardiac, vascular, respiratory, hepatic, renal, neuromuscular disorders, or small joint arthritis. Patients receiving medications known or suspected to affect normal neuromuscular transmission were also excluded.
All children were premedicated with oral midazolam 0.5 mg.kg -1 given 20 to 30 minutes before surgery. Adult patients were premedicated with oral diazepam 10 to 15 mg given approximately 60 minutes before surgery. In the operating room, an intravenous (IV) infusion of warm 5% dextrose in 0.45% saline solution was given at a rate of 4 to 6 ml.kg -1 .hr -1 . The electrocardiogram (ECG) was monitored continuously and arterial blood pressure was measured every five minutes using oscillotonometry. Anaesthesia was induced with sleep doses of propofol (3 to 5 mg.kg -1 in children and 2 to 3 mg.kg -1 in adults) and fentanyl 2 to 4 µg.kg -1 . Endotracheal intubation was performed without the use of neuromuscular blocking drugs. Anaesthesia was maintained by the inhalation of nitrous oxide (N 2 O) 70% in oxygen (O 2 ) and an age-adjusted end-tidal isoflurane concentration of one minimum alveolar concentration (MAC) excluding N 2 O (1.4 to 1.6% in children and 1 to 1.2% in adults) 10 . Incremental doses of fentanyl 1 µg.kg -1 were given as required. Ventilation was controlled to maintain normocapnia. Nasopharyngeal temperature in the two age groups was maintained between 36 and 37°C. Concentrations of isoflurane, N 2 O and end-tidal CO 2 were monitored continuously by a multiplegas analyser (Capnomac Ultima-SVI, Datex Instrumentarium Corporation, Helsinki, Finland) as was pulse oximetry.
A TOF Guard neuromuscular monitor (Biometer International, Odense, Denmark) was used to stimulate the ulnar nerve supramaximally at the wrist with square wave pulses of 0.2 ms duration, delivered in a TOF sequence at 2 Hz repeated every 15 seconds. An acceleration piezo-electric transducer (Biometer International, Odense, Denmark) was fastened to the volar surface of the distal phalanx of the thumb contralateral to the site of IV fluid infusion. For both children and adults, the arm was wrapped and immobilized in a splint. Free movement during evoked thumb adduction was ensured by fixation of the extended four ulnar fingers with adhesive tape. The temperature of the skin overlying the adductor pollicis muscle was monitored using a thermistor incorporated in the TOF-Guard neuromuscular monitor and maintained at a level of 32 to 33°C.
After stabilization of the evoked TOF responses (minimum of 10 min), each patient in the two age groups received one single IV bolus dose of cisatracurium 0.1 mg.kg -1 . The onset time of cisatracurium-induced neuromuscular block (the time interval between the end of injection of cisatracurium and the development of maximum block); and the time required for spontaneous recovery of the first twitch in the TOF response (T1) to a value of 10% of its control, were determined for all patients. Edrophonium antagonism was induced when T1 had spontaneously recovered to a value of 10%. Patients in the two study age groups were allocated randomly into five equal dose blocks, n=12 each (sealed envelope method). Patients in each age group were given either no reversal, or one of four doses of edrophonium (0.1, 0.2, 0.4, and 1 mg.kg -1 ). Atropine 5 µg.kg -1 was combined with edrophonium doses of 0.1 or 0.2 mg.kg -1 and 10 µg.kg -1 with edrophonium doses of 0.4 and 1.0 mg.kg -1 . No other antagonist was given for the next 10 minutes, and the end-tidal isoflurane concentration was not altered. The first twitch height and TOF ratios (fractional height of the evoked fourth twitch in the TOF response in relation to the first twitch height T4/T1%) were recorded every 15 seconds over 10 minutes in all groups. Additional doses of edrophonium and atropine were given if adequate neuromuscular recovery (TOF ratio of 80%) was not achieved at the end of the 10 minutes. All neuromuscular and skin temperature data were recorded on a memory card and a computer printout was obtained for each patient using TOF Guard Reader software (Biometer International, Odense, Denmark).
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Statistical Analyses
The unpaired two-tailed t test was used to compare the two age groups with respect to the onset times, times to 10% T1 recovery, and TOF ratios at five and 10 minutes in the control and after different doses of edrophonium. For each age group, Dunnett's test was used to compare the degree of recovery of TOF ratio recorded at five and 10 minutes after different doses of edrophonium to the corresponding values recorded in the control spontaneous recovery group. Dose-response curves were constructed using the log dose versus the probit transformation of TOF ratio recovery. Regression lines were constructed at five and 10 minutes for children and adults. The effective doses of edrophonium required to achieve a TOF ratio of 50%, 70%, and 80% (ED TOF-50 , ED TOF-70 , ED TOF-80 ) at five and 10 minutes after antagonist administration were determined, in the two age groups, from a standard equation using the slope obtained from regression analysis. All results are expressed as means (SD) and are considered statistically significant when the P-value is less than 0.05. Statistical analyses were performed with the use of Statistical Analysis System (SAS) 6.12, 1998.
RESULTS
All patients in the two age groups completed the study. The mean (SD) age and weight was 5.3 (1.6) years and 16.4 (6.7) kg in the children and 34.3 (7.2) years, 68.2 (5.7) kg in the adults. All patients developed 100% neuromuscular block in response to the bolus doses of cisatracurium. The onset time of cisatracurium-induced block in children was faster than adults, 2.4±0.8 versus 4.1± 2.3 minutes, P<0.01. The time required for 10% spontaneous recovery of T1 was shorter in children than adults, 28.4±5.2 versus 41.8±6.1 minutes, P<0.01.
There was a statistical difference between controls and all doses of edrophonium with respect to recovery of the first twitch and TOF ratio and for both children and adults at five and 10 minutes. Spontaneous and antagonist assisted neuromuscular recovery were more rapid in children than in adults (Table 1, Figures 1, 2) . Only the 0.4 mg.kg -1 and 1 mg.kg -1 doses of edrophonium resulted in more than 90% recovery of T1 by the end of the 10-minute study period in children. In adults, only the highest dose of edrophonium (1 mg.kg -1 ) resulted in more than 90% recovery (92±2.4%) recovery of T1 after 10 minutes (Table 1 and Figure 1 ). Adequate neuromuscular recovery (TOF ratio 80%) was achieved in children at three and 10 minutes after initial administration of edrophonium 1 mg.kg -1 and 0.4 mg.kg -1 , respectively ( Figure 2) . A TOF ratio recovery of 80% was not achieved by any of the four dose levels of edrophonium in adults within the 10-minute study period. It is interesting to note that, with respect to TOF recovery, edrophonium 0.2 mg.kg -1 in children was as effective as 1 mg.kg -1 in adults after 10 minutes (Table 1 and Figure 2) .
The effective doses of edrophonium were significantly lower in children compared to adults. The calculated edrophonium ED TOF-70 , ED TOF-80 after five minutes and ED TOF-80 after 10 minutes in adults were outside the range of doses tested. The calculated ED TOF-70 for edrophonium at 10 minutes in adults was more than four fold the corresponding value in children (Figure 3 , Table 2 ).
DISCUSSION
In the present study, we compared edrophonium dose requirements for antagonism of cisatracuriuminduced neuromuscular block in children and adults. The anaesthetic and neuromuscular monitoring techniques were comparable in the two age groups and equal doses of edrophonium were used to antagonize a 90% neuromuscular block after single bolus doses of cisatracurium. Compared to adults, children had a more rapid onset and a more rapid rate of spontaneous neuromuscular recovery after cisatracurium. Further, substantially lower doses of edrophonium were required to achieve adequate neuromuscular recovery (TOF ratio 80%) in children compared to adults.
Antagonism of neuromuscular blockade by edrophonium and neostigmine depends on an increase in the ratio of acetylcholine to muscle relaxant at the neuromuscular junction, followed by continued elimination of the relaxant from plasma 11 . In children, the more rapid circulation time and increased cardiac output are expected to expedite drug delivery to the neuromuscular junction and its removal [12] [13] [14] . This should accelerate both the onset of neuromuscular block and the rate of spontaneous recovery in children. Both our results and others 8 demonstrate this pattern of cisatracurium action in children. The difference in the rate of spontaneous neuromuscular recovery from cisatracurium-induced block between the two age groups is sufficient to account for the more rapid rate of antagonist-assisted recovery, the reduced edrophonium dose requirements, and the more complete recovery observed in children at the end of the 10-minute study period.
Our results are consistent with the results of previous studies of neostigmine antagonism of intermediate duration neuromuscular blockers 4 and with neostigmine and edrophonium antagonism of longacting 3 and short-acting 5 neuromuscular blockers in the two age groups. In contrast to our findings however, Fisher and colleagues reported that compared to adults, infants and children require higher doses of edrophonium for 50% antagonism of a continuous infusion of d-tubocurarine 15 Values are means (SD) *Significantly different from the same dose level of edrophonium in adults. †Significantly different from the control in the same age group. the recovery characteristics and dose requirements of anticholinesterases may vary with the use of different duration neuromuscular blockers 16 , or even with the use of neuromuscular blocking drugs with comparable duration 9, 17 . Second, the experimental design of the edrophonium/d-tubocurarine study 15 is not clinically relevant because d-tubocurarine continued to be infused after the administration of edrophonium. Continuous infusion of a neuromuscular blocker during the reversal process allows assessment of the ability of anticholinesterases to antagonize nondepolarizing neuromuscular block separate to the effect of spontaneous recovery. The clinically important impact of spontaneous recovery on the reversal process is overlooked. In the present study, and in other antagonist dose-response studies 4, 9, 17 , edrophonium was given only after appreciable spontaneous recovery of the first twitch following a single bolus dose of intermediate duration neuromuscular blocking drug, thereby obtaining data that are more clinically relevant. In contrast to the findings in children, a dose of 1 mg.kg -1 edrophonium in adults who had recovered to 90% neuromuscular block failed to achieve a TOF ratio of 80% within 10 minutes. The calculated edrophonium ED TOF-80 at five and 10 minutes in adults exceeded the upper limit (1 mg.kg -1 ) of the dose range studied. Similarly, Stevens and colleagues have demonstrated that relatively high doses of neostigmine (0.074 mg.kg -1 ) are required to achieve a TOF ratio of 80% 10 minutes after the antagonism of a 90% cisatracurium-induced neuromuscular block in adults 9 . The continued use of isoflurane anaesthesia Values are means (SD). The EDTOF-70 and EDTOF-80 at five minutes and EDTOF-80 at 10 minutes in adults were all outside the edrophonium dose range included in the study.
during the reversal process in the present study may be partly responsible for the inadequate neuromuscular recovery after the use of edrophonium in adults. The use of one MAC isoflurane or sevoflurane has been reported to result in significant impairment of edrophonium-induced antagonism of 90% vecuronium-induced neuromuscular block in adults 18 .
In common with most of the neuromuscular antagonist studies, we used different doses of edrophonium to antagonize a 90% neuromuscular block 19 . At this level of block, variability in response to edrophonium was demonstrated in the present study as well as in other edrophonium antagonism studies in children 6, 20 and adults 21 . The edrophonium effective dose required to achieve a TOF ratio of 80% (ED TOF-80 ) at 10 minutes in children in the present study was mean (SD) 0.38 (0.19) mg.kg -1 . With a relatively high standard deviation, clinicians may choose to use doses higher than the ED TOF-80 to ensure rapid and consistent antagonism of cisatracurium-induced block in children. An alternate approach to resolve the problem of inconsistent antagonism of deep neuromuscular block with edrophonium is to wait for a better degree of neuromuscular recovery before attempting antagonism. Beemer and colleagues 22 suggested that the administration of edrophonium after spontaneous recovery of the fourth response to TOF stimulation reduces variability in response and ensures rapid reliable antagonism of residual atracurium block in adults. The latter approach may be utilized when clinical doses of edrophonium are used to antagonize cisatracurium-induced neuromuscular block in adults receiving N 2 O-isoflurane anaesthesia.
We have chosen a relatively stringent end-point for adequate neuromuscular recovery (TOF ratio 80%) after the administration of edrophonium in children and adults. For many years, a TOF ratio of 70%, measured mechanically at the thumb, was considered to reflect adequate neuromuscular recovery 23 . Recent expert recommendations call for a TOF ratio in the range of 80 to 90% to ensure normal function of upper airway and pharyngeal musculature [24] [25] [26] [27] . Eriksson and colleagues have shown that a TOF ratio of 70% is associated with functional impairment of the muscles of the pharynx and upper oesophagus, predisposing to regurgitation and aspiration 28 .
In conclusion, during isoflurane-N 2 O anaesthesia, when an acceleration piezo-electric transducer was used to monitor the effects of different doses of edrophonium for antagonism of 90% block after a single bolus dose of cisatracurium 0.1 mg.kg -1 , this study demonstrated that compared to adults, children have significantly faster spontaneous and antagonistassisted neuromuscular recovery. The effective doses of edrophonium for 50%, 70%, and 80% recovery of the TOF ratio in children are significantly lower than adults. The variability in edrophonium dose requirement in children may favour the use of doses higher than the ED TOF-80 in the clinical setting to ensure rapid and consistent adequate neuromuscular recovery.
